Jeffery A. Smisek's Insider Trades & SAST Disclosures
Jeffery A. Smisek's most recent trade in Finch Therapeutics Group Inc was a trade of 894,955 Common Stock done . Disclosure was reported to the exchange on March 23, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jeffery A. Smisek.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Finch Therapeutics Group Inc | Jeffery A. Smisek | Director | 23 Mar 2021 | 894,955 | 894,955 | - | - | Common Stock | ||
| Finch Therapeutics Group Inc | Jeffery A. Smisek | Director | 23 Mar 2021 | 894,955 | 0 | - | - | Series A Preferred Stock | ||
| Finch Therapeutics Group Inc | Jeffery A. Smisek | Director | 23 Mar 2021 | 297,178 | 1,334,061 | - | - | Common Stock | ||
| Finch Therapeutics Group Inc | Jeffery A. Smisek | Director | 23 Mar 2021 | 297,178 | 0 | - | - | Series C Preferred Stock | ||
| Finch Therapeutics Group Inc | Jeffery A. Smisek | Director | 23 Mar 2021 | 272,245 | 1,606,306 | - | - | Common Stock | ||
| Finch Therapeutics Group Inc | Jeffery A. Smisek | Director | 23 Mar 2021 | 272,245 | 0 | - | - | Series D Preferred Stock | ||
| Finch Therapeutics Group Inc | Jeffery A. Smisek | Director | 23 Mar 2021 | 141,928 | 1,036,883 | - | - | Common Stock | ||
| Finch Therapeutics Group Inc | Jeffery A. Smisek | Director | 23 Mar 2021 | 141,928 | 0 | - | - | Series B Preferred Stock | ||
| Finch Therapeutics Group Inc | Jeffery A. Smisek | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 23 Mar 2021 | 88,235 | 1,694,541 | - | 17 | 1,499,995 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges